Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Indian Medical Devices Industry Could Reach US$50 Billion by 2030

The Indian medical devices industry has the power to emerge as the global leader in manufacturing and innovation in next the 25 years. It has the potential to grow at 28% per annum to reach US$ 50 billion, according to the Minister of Chemicals and Fertilizer, Mansukh Mandaviya.

The Minister stated this during the launching of a website for the India MedTech Expo 2022 (IMTE-22). The three-day event, which is being spearheaded by the government in association with the Indian medical devices industry, will be held on 9 December in Delhi.

Mandaviya said that the current Indian government plans to redesign aspirations in the pharmaceutical and medical device sector and build an ecosystem for innovation in medical devices and drugs. This would enhance industry-academia linkages. He claimed that the sector’s contribution has increased since the country supported the domestic and global battle against the COVID-19 pandemic by producing medical devices and diagnostic kits, such as ventilators, Rapid Antigen Test kits, RT-PCR kits, and IR thermometers.

India has skilled manpower, promotes ease of business through industry-friendly rules, and offers a huge market. The Minister emphasised that India has the potential to be one of the top 20 global medical device markets. He said he was confident that the industry could achieve a 10-12% share in the expanding global market over the next 25 years.

Medical devices constitute a multi-disciplinary sector with five main categories: electronic equipment, implants, consumables and disposables, surgical instruments, and in-vitro diagnostic reagents. Several segments in the medical device industry are highly capital-intensive with a long gestation period. They require the continuous induction of new technologies and training of healthcare professionals to adapt to new technologies and bring rapid innovation.

Medical devices undergo safety, quality, and efficacy tests through processes defined by the regulator before they are put on the market for sale. The current market size of the medical devices sector in India is about US $11 billion and its share in the global medical device market is estimated to be is 1.5%. The sector in India is witnessing rapid growth, Mandaviya noted, with a CAGR of 10-12% over the last decade.

IMTE-22 is the first edition of the event and is being coordinated by the Federation of Indian Chambers of Commerce & Industry (FICCI). It is planned around the theme ‘The Future of Device, Diagnostics And Digital’. The event will create opportunities to network and explore collaborations both for the sector’s growth in India and its potential contribution globally. It will bring together PLI participants, start-ups, innovative entrepreneurs, R&D facilities, incubators, public and private hospitals, research institutions, and investors, state governments.

These stakeholders will deliberate on key sectoral issues, collaborate, and create opportunities to not only make India self-reliant but also transform it into a global med-tech hub by 2047. IMTE-22 will offer a unique platform to meet and interact with over start-ups, 150 medical device companies, and 50 research institutions.

Furthermore, IMTE-22 will feature special government and state focus pavilions, R&D pavilions, and parallel thematic conference sessions, and will showcase medical tech developed by innovators, companies, and R&D institutions.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.